Wang GR - Search Results

1

Immunoglobulin D Multiple Myeloma: Disease Profile, Therapeutic Response, and Survival.

Wang GR, Sun WJ, Chen WM, Huang ZX, Zhang JJ, An N, Shen M, Li X. Wang GR, et al. Acta Haematol. 2016;136(3):140-6. doi: 10.1159/000446599. Epub 2016 Jul 14. Acta Haematol. 2016. PMID: 27409804

2

[A retrospective analysis of autologous peripheral blood hematopoietic stem cell mobilizations and collections in 149 multiple myeloma patients].

Wang G, Chen W, Li Y, Gao W, Yang G, Li X, Liu J, Yang B. Wang G, et al. Zhonghua Xue Ye Xue Za Zhi. 2015 May;36(5):367-71. doi: 10.3760/cma.j.issn.0253-2727.2015.05.003. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 26031520 Free PMC article. Chinese.

3

A Report of 134 Newly Diagnosed Multiple Myeloma Patients with Renal Impairment.

Liu A, Yang G, Geng C, Wang H, Li L, Li Y, Wu Y, Tian Y, Leng Y, Wang G, Gao W, Chen W. Liu A, et al. Acta Haematol. 2016;135(3):140-5. doi: 10.1159/000440935. Epub 2015 Nov 21. Acta Haematol. 2016. PMID: 26587903

4

Human MutT homologue 1 mRNA overexpression correlates to poor response of multiple myeloma.

Zhou H, Jian Y, Leng Y, Liu N, Tian Y, Wang G, Gao W, Yang G, Chen W. Zhou H, et al. Int J Hematol. 2017 Mar;105(3):318-325. doi: 10.1007/s12185-016-2139-3. Epub 2016 Nov 15. Int J Hematol. 2017. PMID: 27848179

5

Recombinant human thrombopoietin improves the efficacy of intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor in mobilizing peripheral blood stem cells in patients with multiple myeloma: A cohort study.

Wang G, Chen W, Wu Y, Li Y, Leng Y, Liu A. Wang G, et al. Medicine (Baltimore). 2017 Dec;96(50):e9302. doi: 10.1097/MD.0000000000009302. Medicine (Baltimore). 2017. PMID: 29390394 Free PMC article.

6

Immunoparesis recovery 1 year after ASCT is independently associated with favorable survival in patients with symptomatic multiple myeloma who undergo autologous stem cell transplantation.

Gao W, Li J, Wu Y, Li Y, Leng Y, Liu A, Yang G, Tian Y, Wang H, Wang G, Wu Z, Ren Z, Chen W. Gao W, et al. Ann Hematol. 2019 May;98(5):1177-1184. doi: 10.1007/s00277-018-3574-4. Epub 2019 Jan 4. Ann Hematol. 2019. PMID: 30610278 Clinical Trial.

7

Gain of 1q21 is an adverse prognostic factor for multiple myeloma patients treated by autologous stem cell transplantation: A multicenter study in China.

Gao W, Jian Y, Du J, Li X, Zhou H, Zhang Z, Yang G, Wang G, Tian Y, Li Y, Wu Y, Fu W, Li J, Chen W. Gao W, et al. Cancer Med. 2020 Nov;9(21):7819-7829. doi: 10.1002/cam4.3254. Epub 2020 Sep 2. Cancer Med. 2020. PMID: 32881351 Free PMC article.

8

What Multiple Myeloma With t(11;14) Should Be Classified Into in Novel Agent Era: Standard or Intermediate Risk?

Gao W, Du J, Liu J, Zhou H, Zhang Z, Jian Y, Yang G, Wang G, Tian Y, Li Y, Wu Y, Fu W, Li J, Chen W. Gao W, et al. Front Oncol. 2020 Oct 26;10:538126. doi: 10.3389/fonc.2020.538126. eCollection 2020. Front Oncol. 2020. PMID: 33194599 Free PMC article.

9

Novel Non-coding RNA Analysis in Multiple Myeloma Identified Through High-Throughput Sequencing.

Lu M, Wu Y, Gao W, Tian Y, Wang G, Liu A, Chen W. Lu M, et al. Front Genet. 2021 May 24;12:625019. doi: 10.3389/fgene.2021.625019. eCollection 2021. Front Genet. 2021. PMID: 34108986 Free PMC article.

10

Autologous peripheral blood stem cell transplantation as front-line therapy for myeloma with double-hit and triple-hit in a real-world study.

Yang GZ, Wang GR, Li YC, Wu Y, Gao W, Chen WM. Yang GZ, et al. Among authors: wang gr. Chin Med J (Engl). 2021 Jul 19;134(16):1991-1993. doi: 10.1097/CM9.0000000000001678. Chin Med J (Engl). 2021. PMID: 34282065 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters